| UniProt ID | CTU1_HUMAN | |
|---|---|---|
| UniProt AC | Q7Z7A3 | |
| Protein Name | Cytoplasmic tRNA 2-thiolation protein 1 {ECO:0000255|HAMAP-Rule:MF_03053} | |
| Gene Name | CTU1 {ECO:0000255|HAMAP-Rule:MF_03053} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 348 | |
| Subcellular Localization | Cytoplasm. | |
| Protein Description | Plays a central role in 2-thiolation of mcm(5)S(2)U at tRNA wobble positions of tRNA(Lys), tRNA(Glu) and tRNA(Gln). Directly binds tRNAs and probably acts by catalyzing adenylation of tRNAs, an intermediate required for 2-thiolation. It is unclear whether it acts as a sulfurtransferase that transfers sulfur from thiocarboxylated URM1 onto the uridine of tRNAs at wobble position.. | |
| Protein Sequence | MPAPPCASCHAARAALRRPLSGQALCGACFCAAFEAEVLHTVLAGRLLPPGAVVAVGASGGKDSTVLAHVLRALAPRLGISLQLVAVDEGIGGYRDAALAAVRRQAARWELPLTVVAYEDLFGGWTMDAVARSTAGSGRSRSCCTFCGVLRRRALEEGARRVGATHIVTGHNADDMAETVLMNFLRGDAGRLARGGGLGSPGEGGALPRCRPLQFASQKEVVLYAHFRRLDYFSEECVYAPEAFRGHARDLLKRLEAARPSAVLDLVHSAERLALAPAARPPRPGACSRCGALASRALCQACALLDGLNRGRPRLAIGKGRRGLDEEATPGTPGDPARPPASKAVPTF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 81 | Phosphorylation | LAPRLGISLQLVAVD HHHHHCCEEEEEEEE | 14.31 | - | |
| 94 | Phosphorylation | VDEGIGGYRDAALAA EECCCCCHHHHHHHH | 10.50 | - | |
| 126 | Phosphorylation | EDLFGGWTMDAVARS EHHHCCCCHHHHHHC | 14.40 | 26074081 | |
| 133 | Phosphorylation | TMDAVARSTAGSGRS CHHHHHHCCCCCCCC | 16.93 | 26074081 | |
| 134 | Phosphorylation | MDAVARSTAGSGRSR HHHHHHCCCCCCCCH | 29.50 | 26074081 | |
| 137 | Phosphorylation | VARSTAGSGRSRSCC HHHCCCCCCCCHHHH | 28.68 | 26074081 | |
| 140 | Phosphorylation | STAGSGRSRSCCTFC CCCCCCCCHHHHHHH | 31.88 | 26074081 | |
| 142 | Phosphorylation | AGSGRSRSCCTFCGV CCCCCCHHHHHHHHH | 18.13 | 26074081 | |
| 145 | Phosphorylation | GRSRSCCTFCGVLRR CCCHHHHHHHHHHHH | 26.70 | 26074081 | |
| 194 | Methylation | GDAGRLARGGGLGSP CCHHHHHCCCCCCCC | 49.21 | - | |
| 200 | Phosphorylation | ARGGGLGSPGEGGAL HCCCCCCCCCCCCCC | 34.47 | 29255136 | |
| 234 | Phosphorylation | FRRLDYFSEECVYAP HHHCCCCCHHHCCCC | 26.68 | 28348404 | |
| 319 | Ubiquitination | RPRLAIGKGRRGLDE CCCEEECCCCCCCCC | 43.03 | 27667366 | |
| 329 | Phosphorylation | RGLDEEATPGTPGDP CCCCCCCCCCCCCCC | 26.07 | 29255136 | |
| 332 | Phosphorylation | DEEATPGTPGDPARP CCCCCCCCCCCCCCC | 25.87 | 29255136 | |
| 342 | Phosphorylation | DPARPPASKAVPTF- CCCCCCHHHCCCCC- | 27.24 | 22199227 | |
| 343 | Ubiquitination | PARPPASKAVPTF-- CCCCCHHHCCCCC-- | 56.35 | 29967540 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CTU1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CTU1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CTU1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| URM1_HUMAN | URM1 | physical | 19017811 | |
| HSP74_HUMAN | HSPA4 | physical | 19017811 | |
| CTU2_HUMAN | CTU2 | physical | 19017811 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200, AND MASSSPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200, AND MASSSPECTROMETRY. | |